Tag Archives: TBTC

Tuberculosis drug maker Sanofi drops price, easing access to shortened TB infection treatment

By on .

It was Christmas come early for publicly funded TB programs and for advocates of improved tuberculosis regimens when the maker of a rifapentine, a drug that can shorten treatment for tuberculosis infection from as much as nine months to three months announced Thursday it will drop its price for the medicine to a dollar a […]

Advocates, physicians to pharmaceutical company: lower price on government-supported drug, aid research

By on .

It has been heralded as an important step in ending the threat of tuberculosis in the United States, and one with ramifications for countries with higher incidence of the disease: a new drug to treat TB infection before it causes illness, treat it more quickly than current regimens. With standard treatment consisting of daily pills […]

Budget cuts endanger the CDC’s Tuberculosis Research Program

By on .

The following is a guest post by Coco Jervis, senior U.S.and global policy associate Treatment Action Group , the science-based treatment advocacy organization. According to the World Health Organization, an estimated 8.7 million people became sick with tuberculosis in 2011, and more than 1 million are expected to die of the disease this year alone. […]

With TB research threatened, doctors, patients, advocates and filmmakers spell out risks

By on .

At a recent conference of medical researchers, National Institute of Allergy and Infectious Diseases Director Anthony Fauci spelled out what lawmakers appear to be missing in their budget balancing efforts. “They don’t realize,” Fauci said, “that hitting biomedical research now is going to have an impact, three, four years from now.” So efforts to let […]